Harvard Medical School, Boston, MA, USA.
BJOG. 2010 Jan;117(1):32-8. doi: 10.1111/j.1471-0528.2009.02416.x.
To determine whether the presence of bowel obstruction at the time of initial presentation has any prognostic significance in these women.
Retrospective cohort study.
Dedicated gynaecological oncology service of a large tertiary institution.
Women who had a bowel obstruction as part of their initial presentation of ovarian cancer were identified between 1995 and 2007. Each woman was matched with four control women (with disease but no obstruction).
Women with disease were compared with controls to determine the impact, if any, of bowel obstruction at presentation. Several prognostic variables including bowel obstruction were also evaluated in a Cox proportional hazard model.
Progression-free survival (PFS) and overall survival (OS).
Forty-eight women with disease and 192 controls were identified during the study period. The median follow-up period was 19 months among women with disease versus 20 months in controls. No differences were seen in demographics and clinical characteristics of the women. Optimal cytoreduction rate was similar between the two groups (75% versus 78%, P = 0.7). Patients with bowel obstruction had a shorter PFS and OS compared with controls [19 months versus 21 months (P = 0.01) and 22 versus 35 months (P = 0.008)], respectively. Bowel obstruction at presentation was an independent prognostic variable with a hazard ratio of 1.5 (P = 0.009). Other prognostic variables were age, stage and extent of surgical cytoreduction.
Bowel obstruction at the time of initial presentation is an adverse prognostic factor in women with ovarian cancer.
确定初次就诊时是否存在肠梗阻对这些女性患者是否具有预后意义。
回顾性队列研究。
大型三级机构的专门妇科肿瘤服务处。
1995 年至 2007 年间,确定了以肠梗阻为初始卵巢癌表现的女性患者。每位女性患者与 4 名对照女性(患有疾病但无肠梗阻)相匹配。
回顾性队列研究。
在研究期间,确定了以肠梗阻为表现的疾病患者,并与对照组进行了比较,以确定肠梗阻在初次就诊时的影响。还在 Cox 比例风险模型中评估了包括肠梗阻在内的几个预后变量。
无进展生存期(PFS)和总生存期(OS)。
在研究期间,共确定了 48 名患有疾病的女性和 192 名对照。患有疾病的女性中位随访期为 19 个月,而对照组为 20 个月。两组女性的人口统计学和临床特征无差异。两组的最佳肿瘤细胞减灭术率相似(75%与 78%,P = 0.7)。与对照组相比,肠梗阻患者的 PFS 和 OS 更短[19 个月与 21 个月(P = 0.01)和 22 个月与 35 个月(P = 0.008)]。初次就诊时的肠梗阻是独立的预后因素,风险比为 1.5(P = 0.009)。其他预后因素包括年龄、分期和手术肿瘤细胞减灭术的范围。
初次就诊时出现肠梗阻是卵巢癌患者的不利预后因素。